Pharmaceutical and medical products maker Abbott Laboratories Inc. has announced settlements totaling about $184 million for a federal court case involving class action claims over its popular cholesterol medication TriCor.
Pharmaceutical and medical products maker Abbott Laboratories Inc. has announced settlements totaling about $184 million for a federal court case involving class action claims over its popular cholesterol medication TriCor.